Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists

Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists

US Patent 6525070 · Granted Feb 25, 2003

Estimated economic value: $5,431,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MPO inhibitors for use in medicine2023
MPO inhibitors for use in medicine2022
Tetrahydro-benzo[d]azepine derivatives as GPR120 modulators2022
Kinase inhibitors2019
Urea derivatives useful as kinase inhibitors2018
Triazolo(4,5-D)pyrimidine compounds2017
Kinase inhibitors2016
Bi-aryl amide compounds as CRTh2 receptor modulators2013
Piperidine derivatives2012
Phenoxypyridinylamide compounds2012
Pyrazine derivatives2012
Substituted indoles2012